Clobetasol propionate
Sold as Dovate, Xenovate, Clobex, Glencosol m/m, Glencosol foam, Glencosol, Glencosol shampoo, Clonetastra, Clobetasol shalina, Clobex shampoo, Dermovate, Dermovate scalp application
[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
Drag to rotate. Structure from PubChem CID 32798.
Background
Registration
- Applicants
- 6
- Registrations
- 15
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharmacare limited û woodmeadCertificate held by Pharmacare limited | Dovate, Xenovate | 2,5 mg/5,0 g, 2,5 mg/ 5 g, ointment, cream | 270122, 270316, 280611, 280728 | S4 | PIPIL |
| Galderma Laboratories S.A. (Pty) LtdCertificate held by Galderma Laboratories South Africa (Pty) Ltd1 of 2 cancelled | Clobex, Clobex shampoo | spray, 0.5 mg/g | 460556, A400035 | S4 | PIPIL |
| Glenmark Pharmaceuticals South Africa (Pty) Ltd | Glencosol m/m, Glencosol foam, Glencosol, Glencosol shampoo | 0,05%, emulsion, spray, 0,5 mg | 530398, 530555, 530557, 550073 | S4 | PIPIL |
| Astral Pharma (Pty) Ltd | Clonetastra | Not stated | 560417 | S4 | None |
| Pharmadyne Healthcare (Pty) Ltd | Clobetasol shalina | 0,05 % w/v | 570040 | S4 | PIPIL |
| Sekpharma (Pty) Ltd | Dermovate, Dermovate scalp application | ointment, cream | F0175, F0176, H0268 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Dovate ointment EACH 5 g OINTMENT CONTAINS CLOBETASOL PROPIONATE 2,5 mg | 2,5 mg/5,0 gOintment | 27012227/13.4.1/0122Approved 13 November 2023 | Registered | S4 | PIPIL |
| Dovate cream EACH 5 G CREAM CONTAINS CLOBETASOL PROPIONATE 2,5 MG | 2,5 mg/ 5 gCream | 27031627/13.4.1/0316Approved 13 November 2023 | Registered | S4 | PIPIL |
| Xenovate ointment EACH 5 g OINTMENT CONTAINS CLOBETASOL PROPIONATE 0,0025 g | Ointment | 28061128/13.4.1/0611 | Registered | S4 | None |
| Xenovate cream EACH 5 g CREAM CONTAINS CLOBETASOL PROPIONATE 0,0025 g | Cream | 28072828/13.4.1/0728 | Registered | S4 | None |
| Clobex spray EACH 1,0 g SOLUTION CONTAINS CLOBETASOL PROPIONATE 500,0 ug | Spray | 46055646/13.4.1/0556 | Cancelled | S4 | None |
| Glencosol 0,05% m/m ointment EACH 1,0 g OF OINTMENT CONTAINS CLOBETASOL PROPIONATE 0,5 mg | 0,05%Ointment | 53039853/13.4.1/0398 | Registered | S4 | None |
| Glencosol emulsion foam EACH 1,0 mg FOAM CONTAINS CLOBETASOL PROPIONATE 0,5 mg | Emulsion | 53055553/13.4.1/0555 | Registered | S4 | None |
| Glencosol spray EACH 1,0 g SPRAY SOLUTION CONTAINS CLOBETASOL PROPIONATE 500,0 µg | Spray | 53055753/13.4.1/0557 | Registered | S4 | None |
| Glencosol shampoo | 0,5 mgLiquid | 55007355/13.4.1/0073Approved 28 June 2022 | Registered | S4 | PIPIL |
| Clonetastra EACH 1,0 mg SHAMPOO CONTAINS CLOBETASOL PROPIONATE 0,5 mg | Not listed | 56041756/13.4.1/0417 | Registered | S4 | None |
| Clobetasol cream shalina EACH 1,0 g CREAM CONTAINS CLOBETASOL PRO | 0,05 % w/vCream | 57004057/13.4.1/0040Approved 25 March 2025 | Registered | S4 | PIPIL |
| Clobex shampoo EACH 1,0 g CREAM CONTAINS CLOBETASOL PROPIONATE 0,5 mg | 0.5 mg/gShampoo | A400035A40/13.4.1/0035Approved 12 May 2022 | Registered | S4 | PIPIL |
| Dermovate ointment EACH 100 g OINTMENT CONTAINS CLOBETASOL PROPIONATE 0,05 g | Ointment | F0175F/13.4.1/175 | Registered | S4 | None |
| Dermovate cream EACH 100 g OINTMENT CONTAINS CLOBETASOL PROPIONATE 0,05 g | Cream | F0176F/13.4.1/176 | Registered | S4 | None |
| Dermovate scalp application EACH 100 g LOTION CONTAINS CLOBETASOL PROPIONATE 0.05 g | Not listed | H0268H/13.4.1/268 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Clobetasol propionate
S4: Clobetasol
Consolidated Schedules 06 July 2026, line 5842
Pharmacological class: Corticosteroids with or without anti-infective agents. (class 13.4.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Dovate ointment, Pharmacare limited û woodmead is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.